Delivery Order SPE2DB22D3016-SPE2DB24FAPJ9

Award Date 3/7/24
Potential Completion Date 3/8/24
Potential Value $5.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Amerisourcebergen Drug Corp, through its Corporate Office division, has been awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide TOPAMAX 50 MG TABLET 60S, a pharmaceutical product. The contract has a potential value of $10,765.92 and a completion date of February 20, 2024. This order is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, which serves as the primary vehicle for the company to deliver...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract (SPE2DX15D3012|SPE2DX24F8LM0) by the Defense Logistics Agency (DLA) Troop Support Medical for the provision of TOPAMAX 50 MG TABLET 60S, a pharmaceutical product. The award, valued at $3,258.72, has an ultimate completion date of March 29, 2024. Amerisourcebergen Drug Corp is the prime contractor for this delivery order, which is not designated as a set-aside...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order by the Defense Logistics Agency (DLA) to provide TOPAMAX 200 MG TABLET 60S, a pharmaceutical product. The $4,075.26 contract has a completion date of February 12, 2024 and does not utilize any set-aside designations. This delivery order is issued under Amerisourcebergen Drug Corp's indefinite delivery contract with DLA, valued at up to $999,999,999.00 through December 31,...
Amerisourcebergen Drug Corp has received a $2,065.35 firm fixed price delivery order from the Defense Logistics Agency (DLA) to supply 4562627217 TOPAMAX 100 MG TABLET 60S. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical products to the DLA by October 30, 2023. The delivery order was awarded against an existing indefinite delivery contract and no set-aside designation was used. Amerisourcebergen, a subsidiary of Amerisourcebergen Corporation, routinely supports DLA...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a Firm Fixed Price Delivery Order contract by the Defense Logistics Agency (DLA) to provide TOPAMAX 50 MG TABLET 60S. The total potential value of the contract is $8,629.35 with a completion date of February 22, 2024. This contract is not associated with any set-aside designation. Amerisourcebergen Drug Corp serves as the prime contractor and holds an Indefinite Delivery Contract (IDC) with DLA, with a...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide TOPAMAX 200 MG TABLET 60S. The $8,026.69 award has a completion date of January 30, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor and is also the prime on an indefinite delivery contract (IDC) with DLA with a potential value of $999,999,999.00 through December...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical company AmerisourceBergen Corporation, to supply TOPAMAX 50 MG TABLET 60S medication. The $10,915.77 award has an ultimate completion date of April 11, 2024 and is not associated with any set-aside designations. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a Delivery Order valued at $1,040.53 for the supply of TOPAMAX 100 MG TABLET 60S, a pharmaceutical product. The contract has a completion date of February 10, 2025 and is a Firm Fixed Price arrangement. Amerisourcebergen Drug Corp is the prime contractor, and the contract does not have a set-aside...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TOPAMAX 50 MG TABLET 60S. The contract has a ceiling value of $1,029.00 and is a Firm Fixed Price delivery order with a completion date of September 13, 2024. The contract is not set aside for any specific business type. AmerisourceBergen, through its Corporate Office division, will provide the required pharmaceutical product to support...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical distribution company. The order is for the supply of TOPAMAX 25 MG TABLET 60S, with a potential value of $4,983.51 and a completion date of February 22, 2024. Amerisourcebergen Drug Corp is the prime contractor on this order, which is not associated with any overarching contract vehicles. No set-aside...
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB24FAPJ9
    Delivery Order

Amerisourcebergen Drug Corp, through its Corporate Office division, was awarded a $5,157.69 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide TOPAMAX 50 MG TABLET 60S. This delivery order contract has a completion date of March 8, 2024 and was awarded on March 7, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp is a prime contractor that provides a wide range of pharmaceutical products and medical supplies to U.S. government agencies, particularly the Department of Defense, through various indefinite delivery contracts with the DLA. This specific delivery order supports military treatment programs and facilities.

Generated 6/6/24, 10:20 AM